References
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953-66.
- Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425-34.
- Song Y, Zou X, Gong X, Becoulet A, Buttery R, Bonoli P, et al. Realization of thousand-second improved confinement plasma with Super I-mode in Tokamak EAST. Sci Adv. 2023;9(1):eabq5273.
- Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls; 2022.
- Luo X, Lin X, Gao F, Zhao Y, Li X, Zhan L, et al. Recent progress in perovskite solar cells: from device to commercialization. Sci China Chem. 2022;65:1-48.
- Wu Y, Hou S, Yuan Z, Jiang K, Huang R, Wang K, et al. DNA barcoding of Chinese snakes reveals hidden diversity and conservation needs. Mol Ecol Resour. 2023;23(5):1124-41.
- Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20(6):689-96.
- Apostolou E, Tzioufas AG. Type-III interferons in Sjögren’s syndrome. Clin Exp Rheumatol. 2020;38(Suppl 1):245-52.
- Wu Q, Yang Q, Lourenco E, Sun H, Zhang Y. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity. Arthritis Res Ther. 2011;13:1-12.
- Espinosa De Ycaza AE, Søndergaard E, Morgan-Bathke M, Lytle K, Delivanis DA, Ramos P, et al. Adipose tissue inflammation is not related to adipose insulin resistance in humans. Diabetes. 2022;71(3):381-93.
- Shanmuganathan G, Orujyan D, Narinyan W, Poladian N, Dhama S, Parthasarathy A, et al. Role of Interferons in Mycobacterium tuberculosis infection. Clin Pract. 2022;12(5):788-96.
- Moyo NA, Westcott D, Simmonds R, Steinbach F. Equine arteritis virus in monocytic cells suppresses differentiation and function of dendritic cells. Viruses. 2023;15(1):255.
- Challagundla N, Shah D, Yadav S, Agrawal-Rajput R. Saga of monokines in shaping tumour-immune microenvironment: Origin to execution. Cytokine. 2022;157:155948.
- Hao N, Zhou Z, Zhang F, Li Y, Hu R, Zou J, et al. Interleukin‐29 accelerates vascular calcification via JAK2/STAT3/BMP2 signaling. J Am Heart Assoc. 2023;12(1):e027222.
- Eswadi AR, AL-Hellawi ZH. IL-24 and IL-29 in T2DM with and without diabetic foot ulcers. Acta Chemica IASI. 2022;30(2):103-119.
- Arida E, Ashari H, Dahruddin H, Fitriana YS, Hamidy A, Irham M, et al. Exploring the vertebrate fauna of the Bird’s Head Peninsula (Indonesia, West Papua) through DNA barcodes. Mol Ecol Resour. 2021;21(7):2369-87.
- Lorizate M, Kräusslich H-G. Role of lipids in virus replication. Cold Spring Harb Perspect Biol. 2011;3(10):a004820.
- Hsu N-Y, Ilnytska O, Belov G, Santiana M, Chen Y-H, Takvorian PM, et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010;141(5):799-811.
- Murillo A, Vera-Estrella R, Barkla BJ, Méndez E, Arias CF. Identification of host cell factors associated with astrovirus replication in Caco-2 cells. J Virol. 2015;89(20):10359-70.
- Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters K-A, Proll SC, et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010;6(1):e1000719.
- Gualdoni GA, Mayer KA, Kapsch A-M, Kreuzberg K, Puck A, Kienzl P, et al. Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication. Proc Natl Acad Sci. 2018;115(30):E7158-65.
- Thai M, Thaker SK, Feng J, Du Y, Hu H, Ting Wu T, et al. MYC-induced reprogramming of glutamine catabolism supports optimal virus replication. Nat Commun. 2015;6(1):8873.
- Thai M, Graham NA, Braas D, Nehil M, Komisopoulou E, Kurdistani SK, et al. Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metab. 2014;19(4):694-701.
- Murray JF. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1989;139:1065.
- Rieger A, Blackburn AM, Bystrynski JB, Garthe RC, Allen NE. The impact of the COVID-19 pandemic on gender-based violence in the United States: Framework and policy recommendations. Psychol Trauma. 2022;14(3):471.
- Aluganti Narasimhulu C, Singla DK. Mechanisms of COVID-19 pathogenesis in diabetes. Am J Physiol Circ Physiol. 2022; 323(3):H403–20.
- Vazzano A, Briggs S, Kim L, Parekh J, Manlove J. Adapting family planning service delivery in title X and school-based settings during COVID-19: Provider and staff experiences. Int J Environ Res Public Health. 2023;20(4):3592.
- Baillargeon J, Polychronopoulou E, Kuo Y-F, Raji MA. The impact of substance use disorder on COVID-19 outcomes. Psychiatr Serv. 2021;72(5):578-81.
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
- Moran KR, Del Valle SY. A meta-analysis of the association between gender and protective behaviors in response to respiratory epidemics and pandemics. PLoS One. 2016;11(10):e0164541.
- Schmitz KS, Geers D, de Vries RD, Bovier TF, Mykytyn AZ, Geurts van Kessel CH, et al. Potency of fusion-inhibitory lipopeptides against SARS-CoV-2 variants of concern. MBio. 2022; 13(3):e01249-22.
- Broggi A, Granucci F, Zanoni I. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion. J Exp Med. 2019;217(1):e20190295.
- Broggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science. 2020;369(6504):706-12.
- Yang Y, Chen J, Yi C, Yang F, Tang M, Li Z, et al. Assessment of serum interleukin-28 as a biomarker to predict mortality in traumatic patients with sepsis. Cytokine. 2022;157:155959.
- Gondar R, Nouri A, Jannelli G, Schaller K, Tessitore E. Does spondylolisthesis affect severity and outcome of degenerative cervical myelopathy? A systematic review and meta-analysis. Glob Spine J. 2021;11(7):1134-41.
- Kim Y-M, Shin E-C. Type I and III interferon responses in SARSCoV-2 infection. Exp Mol Med. 2021;53(5):750-60.
- Prokunina-Olsson L, Alphonse N, Dickenson RE, Durbin JE, Glenn JS, Hartmann R, et al. COVID-19 and emerging viral infections: The case for interferon lambda. J Exp Med. 2020;217(5).
- Lee JS, Shin E-C. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020;20(10):585-6.
- Andreakos E, Tsiodras S. COVID‐19: lambda interferon against viral load and hyperinflammation. EMBO Mol Med. 2020;12(6):e12465.
- Reis G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, Campos VHS, Ferreira TS, et al. Early treatment with pegylated interferon lambda for covid-19. N Engl J Med. 2023;388(6):518-28.